ImmunityBio, Inc. Logo

ImmunityBio, Inc.

Develops immunotherapies activating the immune system to fight cancer and infectious diseases.

IBRX | NDAQ

Overview

Corporate Details

ISIN(s):
US45256X1037
LEI:
Country:
United States of America
Address:
3530 JOHN HOPKINS COURT, 92121 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ImmunityBio, Inc. is a commercial-stage biotechnology company developing next-generation immunotherapies for cancers and infectious diseases. The company's core strategy is to strengthen the patient's own immune system by activating both its innate and adaptive branches, a comprehensive approach designed to orchestrate a coordinated attack on diseased cells and establish long-term immunological memory. Its clinical pipeline features therapies such as the IL-15 superagonist ANKTIVA®, engineered natural killer (NK) cell platforms, and adenovirus-vectored vaccines. These investigational treatments target a range of conditions, including various solid tumors like bladder and lung cancer, as well as infectious diseases such as HIV. ImmunityBio also provides its NK-92® cell line as a bioanalytical tool for research scientists.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ImmunityBio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ImmunityBio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ImmunityBio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN
ANAVEX LIFE SCIENCES CORP. Logo
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America AVXL
Anbio Biotechnology Logo
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America NNNN
Anebulo Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America ANEB
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
ANI PHARMACEUTICALS INC Logo
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America ANIP
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America ANNX

Talk to a Data Expert

Have a question? We'll get back to you promptly.